| |
|
|
|
The Center for Professional Advancement, 90 Minute Accredited Online Training
May 12, 2009 at 11:00 a.m. - 12:30 p.m. (EST)
Who Should Attend
This online training will benefit professionals in the pharmaceutical industries who select Contract Research Organizations (CROs) for product discovery, development and manufacturing. Specifically, personnel who are involved in the final decision making process of the CRO to be used for the project being proposed, including:
• Research Managers involved in CRO selection, pre-clinical
and clinical
• Research Administrators who scout, interview and select
CROs
• Personnel who select CROs for the manufacturing of drug
substance and product
Description
This 90-minute accredited training course will detail the selection process that will guide personnel who consider CROs to be used for segments or in the entire process required for successful new product development. These include:
Module 1:
• Drug Discovery
• Nonclinical Drug Development
• Clinical Drug Development Provider
• Chemistry, Manufacturing, and Control
Module 2:
• Types of Outsourcing Venders
• Mega-CROs
• Small/Mid-size CROs
• Niche Providers
Module 3:
• Outsourcing Strategies
• Virtual
• Pre-selected or Preferred
• Special Trials
Question and Answer Session
|
|
|
|
|
|
|
|
Organized by:
|
|
The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
Dr. Richard A. Guarino, President, Oxford Pharmaceutical Resources, Inc.
Richard A. Guarino, M.D. is President of Oxford Pharmaceutical Resources, Inc., a consulting organization specializing in the planning, implementing and submitting of INDs, NDAs and CTDs. Dr. Guarino also has 25 years of experience in new drug applications, in marketing launches, advertising and FDA liaison.
Dr. Guarino was formerly the President and CEO of Oxford Research International Corp., one of the largest CROs in the United States. Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc., now Novartis, and held the position of Vice President/Medical Director at Revlon Healthcare Group. He has been acclaimed for his book, New Drug Approval Process, now in its 4th edition. It is the first book ever written to guide and recommend ways to expedite global new drug approval process while following all the requirements of the Code of Federal Regulations and EU Directives.
Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Columbus Foundation, Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
salbers@cfpa.com
|
|
|
|
|
|
|
|
|